您的位置: 首页 > 农业专利 > 详情页

METHOD OF EPIGENETIC ANALYSIS FOR DETERMINING CLINICAL GENETIC RISK
专利权人:
发明人:
Andrew P. Feinberg,Andrew Ellis Jaffe,Juleen Rae Zierath,Erik Bertil Naeslund,Guang William Wong
申请号:
US15541455
公开号:
US20180148783A1
申请日:
2016.01.05
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention provides a method for identifying a subject having or at risk of having a metabolic disease, such as diabetes or obesity. The invention is based on an approach to identify candidate genes involved in metabolic diseases, such as obesity and type 2 diabetes (T2D) through epigenetic mechanisms. The method includes identifying in the subject genetic markers correlating differentially methylated regions (DMRs) in the genome with genetic risk loci for the subject and comparing methylation patterns of the markers with a control sample from a subject not having the disease. In another embodiment, the invention also provides a method of treating a subject having or at risk of having a metabolic disease. In another embodiment, the invention provides a method of providing a prognostic evaluation of a subject having or at risk of having a metabolic disease.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充